Abstract:Extensive research has explored the role of gut microbiota in colorectal cancer (CRC). Nonetheless, metatranscriptomic studies investigating the in situ functional implications of host-microbe interactions in CRC are scarce. Therefore, we characterized the influence of CRC core pathogens and biofilms on the tumor microenvironment (TME) in 40 CRC, paired normal, and healthy tissue biopsies using fluorescence in situ hybridization (FISH) and dual-RNA sequencing. FISH revealed that Fusobacterium spp . was associated with increased bacterial biomass and inflammatory response in CRC samples. Dual-RNA sequencing demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors in CRC samples with high bacterial activity. In addition, bacterial activity correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells in CRC samples. Specifically, Bacteroides fragilis and Fusobacterium nucleatum correlated with the infiltration of neutrophils and CD4 + T-cells, respectively. The collective bacterial activity/biomass appeared to exert a more significant influence on the TME than core pathogens, underscoring the intricate interplay between gut microbiota and CRC. These results emphasize how biofilms and core pathogens shape the immune phenotype and TME in CRC while highlighting the need to extend the bacterial scope beyond CRC pathogens to advance our understanding and identify treatment targets.

What problem does this paper attempt to address?

The paper attempts to address the role of the gut microbiome in colorectal cancer (CRC) and its impact on the tumor microenvironment (TME) and immune phenotype. Specifically, the study aims to explore how CRC core pathogens and biofilms affect the TME of 40 CRC cases, paired normal tissues, and healthy tissue samples through fluorescence in situ hybridization (FISH) and dual RNA sequencing techniques. ### Main Research Questions: 1. **Role of CRC Core Pathogens and Biofilms in TME**: Researchers aim to reveal how these pathogens and biofilms influence the TME using FISH and dual RNA sequencing techniques. 2. **Relationship Between Bacterial Activity and Inflammatory Response**: Investigate whether increased bacterial activity in CRC samples leads to increased expression of pro-inflammatory cytokines, defensins, matrix metalloproteinases, and immune modulators. 3. **Relationship Between Bacterial Activity and Immune Cell Infiltration**: Analyze whether bacterial activity is associated with the infiltration of specific immune cell subtypes such as M2 macrophages and regulatory T cells. 4. **Impact of Different Bacterial Species**: Study the roles of Bacteroides fragilis and Fusobacterium nucleatum in neutrophil and CD4+ T cell infiltration. 5. **Comparison of Overall Bacterial Activity and Core Pathogens**: Evaluate whether the impact of overall bacterial activity/biomass on the TME is more significant than that of core pathogens. ### Research Background: - **Relationship Between Microbiome and CRC**: Multiple studies have shown significant differences in the composition of the gut microbiome in CRC patients, particularly the enrichment of certain specific species. - **Microbial Dysbiosis and CRC Pathogenesis**: Microbial dysbiosis leads to the accumulation of opportunistic bacteria such as Bacteroides fragilis and Fusobacterium nucleatum, increasing tissue inflammation, which is a known risk factor for CRC. - **Limitations of Existing Studies**: Although many studies have explored the role of the microbiome in CRC, most have failed to elucidate the functional impact of microbial activity in the TME. ### Research Methods: - **Sample Collection**: Collect colonic mucosal biopsy samples from 40 CRC patients, paired normal tissues, and healthy controls. - **FISH Technique**: Use specific probes to detect the distribution of Fusobacterium spp. and Bacteroides fragilis. - **Dual RNA Sequencing**: Simultaneously capture the transcriptomes of pathogens and hosts to analyze the impact of bacterial activity on the TME. ### Research Results: - **Relationship Between Fusobacterium spp., Bacterial Biomass, and Inflammatory Response**: Fusobacterium spp. is associated with increased bacterial biomass and acute inflammatory response in CRC samples. - **Transcriptomic Features of High Bacterial Activity Samples**: In samples with high bacterial activity, there is increased expression of pro-inflammatory cytokines, defensins, matrix metalloproteinases, and immune modulators. - **Bacterial Activity and Immune Cell Infiltration**: Bacterial activity is associated with the infiltration of various immune cell subtypes, including M2 macrophages, regulatory T cells, and myeloid dendritic cells. - **Roles of Different Bacterial Species**: Bacteroides fragilis is associated with neutrophil infiltration, while Fusobacterium nucleatum is associated with CD4+ T cell infiltration. - **Impact of Overall Bacterial Activity**: The impact of overall bacterial activity/biomass on the TME may be more significant than that of core pathogens. ### Conclusion: The study highlights how biofilms and core pathogens shape the immune phenotype and TME of CRC, indicating the need to expand the range of bacterial species studied to better understand their functional impacts and identify therapeutic targets.

Biofilms and core pathogens shape the tumor microenvironment and immune phenotype in colorectal cancer

Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression

Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer

The gut microbiota can orchestrate the signaling pathways in colorectal cancer

Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls

Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming

Abstract 3056: Gut microbial co-metabolism influences the tumor microenvironment

Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications

Abstract 2807: Distinctive microbiome signatures in colorectal cancer: A comparative metagenomic analysis

Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer

Gut microbiome: decision-makers in the microenvironment of colorectal cancer

The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments

Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change

Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer

The Role of the Microbiome in the Etiopathogenesis of Colon Cancer

Disease-associated Gut Microbiome and Critical Metabolomic Alterations in Patients with Colorectal Cancer

The gut microbial metabolite formate exacerbates colorectal cancer progression

Exploring the Role of Gut Microbiome in Colon Cancer

Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients

Effect of spatial transcriptomic-derived intrinsic epithelial signatures on immune cell recruitment and behaviour in the microenvironment of colorectal cancer.